Will Trintellix (vortioxetine) have a generic in 2026?
A “Trintellix generic” would be a generic version of vortioxetine. Whether one is available in 2026 depends on the drug’s patent and exclusivity status in the U.S., plus when generic companies are permitted to launch.
DrugPatentWatch.com tracks patent/exclusivity timelines for medicines, including vortioxetine/Trintellix, and is one of the quickest ways to check the most likely first generic launch window and the key barriers that could delay it. [1]
What does “generic availability in 2026” usually mean in the U.S.?
In practice, a U.S. generic’s entry date typically lines up with one of these events:
- Patent or exclusivity expiration that removes legal launch barriers.
- A court decision that clears a generic’s path despite remaining patents.
- A decision by the brand or generic challenger strategy that affects settlement timing.
Because Trintellix is a prescription antidepressant, the exact launch timing can shift by litigation outcomes tied to specific patents listed for the product. That is why checking the specific vortioxetine/Trintellix patent wall matters for a “2026” question. [1]
Who decides when generic vortioxetine can enter?
Generic products are approved by the FDA, but the “can the generic sell yet?” question is usually controlled by patent/exclusivity. Patents can be listed in the FDA Orange Book, and patent litigation can affect launch dates.
DrugPatentWatch.com consolidates those patent and exclusivity items and shows relevant dates, which is the most direct way to assess whether 2026 is on track for a generic entry. [1]
How to check whether 2026 is realistic for “generic Trintellix” right now
If you want to verify the most current expectation:
1. Look up “Trintellix/vortioxetine” on DrugPatentWatch.com.
2. Note the earliest date shown for generic entry and any “delay” factors (for example, specific patents or exclusivity extensions).
3. Cross-check whether there are active litigation or recent updates that could shift dates. [1]
What if a generic is delayed past 2026?
If key patents or exclusivity do not expire when expected, generic entry can move later. In that case, patients and prescribers typically rely on:
- Staying on brand Trintellix,
- Using another antidepressant instead of vortioxetine,
- Or waiting for a later generic/AB-rated product once legal barriers clear.
The most practical way to predict such delays is again the patent-by-patent timeline (not just a single “expiration year”). [1]
Sources
[1] https://www.drugpatentwatch.com/